Financial news, mergers and acquisitions, partnerships, and alliances.
LabCorp and Walgreens will create co-branded testing centers within seven Walgreens located in Denver, North Carolina, and Illinois.
Sweden-based Immunovia is preparing to launch its first diagnostic — a liquid biopsy test for pancreatic cancer — in 2018.
The distribution deal comes less than a month after the firm announced that the FDA cleared for marketing the revogene instrument along with the GenePOC GBS LB assay.
SOL will help Personal Genomics to further develop its research projects and implement its new facility dedicated to DNA sequencing.
The firm established an "at-the-market" program to offer up to $21.2 million of its common stock from time to time. Proceeds will be used for business operations.
